Last checked at 
LONDON (Alliance News) - Hikma Pharmaceuticals PLC said Darhold Ltd, a company in which some of its directors are interested, purchased 70,251 shares at a price of 2,122 pence per share on Thursday.
Chairman and Chief Executive Said Darwazah is a shareholder in Darhold with an equity interest of 21.49%, Executive Vice Chairman Mazen Darwazah holds a 10.82% stake and Non-Executive Director Mohammed Al-Husry has a 7.95% stake. All three are directors of Darhold.
Hikma did not reveal the stake held by the three directors or Darhold after the transaction.
The stock closed down 0.4% to 2,133.00 pence per share on Thursday.
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun
Copyright 2016 Alliance News Limited. All Rights Reserved.
